2024 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2024 Biotech Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Arthur Radley

Lance Bredvold

To: technetium who wrote (30)	1/14/2024 6:44:15 PM
From: BulbaMan	2 Recommendations of 195

I first bought PMN in 2009 back when it was listed in Canada as Amorfix as I believed their chief scientist was brilliant. It also helped that his name was Cashman. The stock has been a disaster but I’ve traded in and out and have only wound up with a small loss. I still own shares but not many after their 1-60 reverse split in June, 2022. Based on its history the stock is likely to soon give up all or most of its recent gains. But in the immortal words of Fats Waller: “One never knows, do one?” Peace & good health, Bulba

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next